By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


G1 Therapeutics 

Chapel Hill  North Carolina    U.S.A.
Phone: n/a Fax: n/a



Company News
Cancer Biotech G1 Therapeutics Files for $115 Million IPO 4/18/2017 6:36:42 AM
G1 Therapeutics Release: Biotech Initiates Three Drug Development Programs In Breast Cancer 1/10/2017 7:00:07 AM
G1 Therapeutics To Evaluate Trilaciclib (G1T28) In Combination With Immune Checkpoint Inhibitor In Small-Cell Lung Cancer 12/5/2016 8:45:09 AM
G1 Therapeutics To Present At Wedbush PacGrow Healthcare Conference 8/10/2016 10:57:45 AM
University of North Carolina Spinout G1 Therapeutics Locks in $47 Million Series C Financing 5/12/2016 6:37:54 AM
G1 Therapeutics To Present At The 18th Annual BIO CEO & Investor Conference 2/2/2016 11:21:38 AM
G1 Therapeutics To Present At The Stifel 2015 Healthcare Conference 11/10/2015 8:36:04 AM
Glenn P. Muir Appointed To G1 Therapeutics Board Of Directors 10/21/2015 7:40:29 AM
G1 Therapeutics To Present At September Biotech Conferences 9/3/2015 7:29:31 AM
G1 Therapeutics Announces Initiation Of Two Phase Ib/IIa Trials Of CDK4/6 Inhibitor G1T28 In Small-Cell Lung Cancer 8/11/2015 7:45:09 AM